Engage Healthcare Comm LLC v. Intellisphere LLC

CourtCourt of Appeals for the Third Circuit
DecidedNovember 20, 2019
Docket19-1017
StatusUnpublished

This text of Engage Healthcare Comm LLC v. Intellisphere LLC (Engage Healthcare Comm LLC v. Intellisphere LLC) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Engage Healthcare Comm LLC v. Intellisphere LLC, (3d Cir. 2019).

Opinion

NOT PRECEDENTIAL

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT ______________

No. 19-1017 ______________

ENGAGE HEALTHCARE COMMUNICATIONS, L.L.C.; GREENHILL HEALTHCARE COMMUNICATIONS, L.L.C.; CENTER OF EXCELLENCE MEDIA, L.L.C.,

Appellants

v.

INTELLISPHERE, L.L.C.; MICHEL J. HENNESSY & ASSOCIATES, INC.; MICHAEL J. HENNESSY; ARC MESA EDUCATORS, L.L.C.; JOHN DOES 1-5; JANE DOES 1-5 ______________

On Appeal from the United States District Court for the District of New Jersey (D.C. Civ. No. 3-12-cv-00787) District Judge: Honorable Freda L. Wolfson ______________

Submitted under Third Circuit L.A.R. 34.1(a) October 25, 2019

BEFORE: GREENAWAY, JR., PORTER, and GREENBERG, Circuit Judges.

(Filed: November 20, 2019) ______________

OPINION* ______________ ____________________

*This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does not constitute binding precedent. GREENBERG, Circuit Judge.

I. INTRODUCTION

In this this trademark infringement action between strikingly similar companies

separately owned by two brothers, we are asked to review the District Court’s opinion

and judgment adjudicating the infringement dispute between them. That Court granted

summary judgment to defendants, finding that they did not infringe the alleged

trademarks owned by plaintiffs. For the reasons stated below, we will affirm the

judgment.

II. FACTUAL BACKGROUND

We rely on the facts the District Court recited in its excellent comprehensive

opinion which we therefore do not repeat at length. See Engage Healthcare Commc’ns,

LLC v. Intellisphere, LLC, No. 12-0787, slip op. at 2-12 (D.N.J. Nov. 29, 2018). At its

core, this is a straightforward trademark dispute. The District Court helpfully

summarized the marks at issue with two tables in its opinion. They are as follows:

Plaintiffs’ Marks Defendants’ Marks

PERSONALIZED MEDICINE IN PERSONALIZED MEDICINE IN ONCOLOGY HEMATOLOGY/ONCOLOGY

PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY

THE ONCOLOGY NURSE ONCNURSE

THE ONCOLOGY NURSE APN/PA

2 Plaintiffs’ Marks Defendants’ Marks

VALUE-BASED CANCER CARE VALUE-BASED ONCOLOGY

VALUE-BASED ONCOLOGY CARE

ONCOLOGY PHARMACY NEWS ONCOLOGY PHARMACY NEWS

CLINICAL ONCOLOGY PHARMACY NEWS

ONCOLOGY PRACTICE ONCOLOGY BUSINESS MANAGEMENT MANAGEMENT

AMERICAN HEALTH & DRUG AMERICAN JOURNAL OF BENEFITS PHARMACY BENEFITS

PEER-SPECTIVES PEERS & PERSPECTIVES

TARGETED THERAPIES IN INTERNATIONAL CONGRESS ON HEMATOLOGY/ONCOLOGY TARGETED THERAPIES IN CANCER

TARGETED THERAPIES IN INTERNATIONAL JOURNAL OF ONCOLOGY TARGETED THERAPIES IN CANCER

TARGETED THERAPIES IN BREAST BIOMARKERS, PATHWAYS, AND CANCER TARGETED THERAPIES

TARGETED THERAPIES IN LUNG TARGETED THERAPY NEWS CANCER

TARGETED THERAPIES IN NONHODGKIN LYMPHOMA

Engage, slip op. at 3-4.

3 Plaintiffs’ Marks Defendants’ Marks

JOURNAL OF PERSONALIZED PERSONALIZED CANCER CARE MEDICINE IN HEMATOLOGY/ONCOLOGY

PERSONALIZED CANCER CARE

PERSONALIZED MEDICINE IN IMMUNOLOGY

PERSONALIZED MEDICINE IN RHEUMOTOLOGY

PERSONALIZED BREAST CANCER

PERSONALIZED VALUE BASED CANCER CARE

4 Plaintiffs’ Marks Defendants’ Marks

PERSONALIZED VALUE BASED VALUE -BASED CARDIOLOGY CANCER CARE VALUE-BASED CARDIOLOGY CARE VALUE-BASED BREAST CANCER VALUE-BASED DESIGN VALUE-BASED CARE IN RHEUMOTOLOGY VALUSE-BASED INSURANCE DESIGN VALUE-BASED CARE IN MULTIPLE MYELOMA

VALUE-BASED ONCOLOGY BENEFIT DESIGN

TRANSLATING EVIDENCE-BASED RESEARCH INTO VALUE-BASED DECISIONS

INSTITUTE FOR VALUE-BASED MEDICINE

CLINICAL ONCOLOGY PHARMACY N/A

RHEUMATOLOGY BUSINESS N/A MANAGEMENT

DERMATOLOGY BUSINESS MANAGEMENT

DIABETES BUSINESS MANAGEMENT

Engage, slip op. at 9-10.

5 III. DISCUSSION

The District Court had jurisdiction under 28 U.S.C. §§ 1331, 1338 and 1367, and

we have jurisdiction under 28 U.S.C. § 1291. We exercise plenary review of the District

Court’s grant of summary judgment and thus consider the issues de novo. See Bradley v.

W. Chester Univ. of Pa. State Sys. of Higher Educ., 880 F.3d 643, 650 (3d Cir. 2018).

Accordingly, we are applying “the same standard as the District Court to determine

whether summary judgment was appropriate.” State Auto Prop. & Cas. Ins. Co. v. Pro

Design, P.C., 566 F.3d 86, 89 (3d Cir. 2009). “[S]ummary judgment is properly granted

‘if the movant shows that there is no genuine dispute as to any material fact and the

movant is entitled to judgment as a matter of law.’” Sconiers v. United States, 896 F.3d

595, 597 n.3 (3d Cir. 2018) (quoting Fed. R. Civ. P. 56(a)).

In granting summary judgment to defendants, the District Court held that (1) none

of plaintiffs’ alleged trademarks were enforceable as advertising marks, thus defendants

could not have infringed them; (2) all but one of plaintiffs’ trademarks were

unenforceable in the online and/or print publication class in the fields of hematology and

oncology that they addressed; and (3) defendants did not infringe the lone valid

trademark. The District Court also held that (4) plaintiffs’ state-law unfair competition

claims failed because under state law, essentially the same standard applied to their unfair

competition claims as their federal trademark claims; and (5) the District Court lacked

subject matter jurisdiction to adjudicate plaintiffs’ request for declaratory judgment to

invalidate defendants’ alleged trademarks. In view of the District Court’s thorough

treatment of the issues and our agreement with its treatment we will affirm its judgment

6 for substantially the same reasons the District Court articulated in its opinion with one

exception which we discuss below. Nevertheless, our rejection of the District Court’s

reasoning on that issue does not change our result which affirms its judgment.

A. Advertising Marks

We agree with the District Court that plaintiffs’ alleged marks could not be

enforced as advertising service marks in this case which at bottom is an argument over

advertising. “Under the Lanham Act, service marks, which are used to identify the

source of services, are entitled to the same legal protection as trademarks, which are used

to identify the source of goods. . . . Although technically distinct, the terms are often

used interchangeably, with no significant legal consequences.” Dranoff-Perlstein Assocs.

v. Sklar, 967 F.2d 852, 855 (3d Cir. 1992) (citation omitted). As such, a court addresses

the question of whether a service mark is entitled to protection under the Lanham Act

using the same standard that it applies when considering trademarks.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Two Pesos, Inc. v. Taco Cabana, Inc.
505 U.S. 763 (Supreme Court, 1992)
In Re Advertising & Marketing Development, Inc.
821 F.2d 614 (Federal Circuit, 1987)
Dranoff-Perlstein Associates v. Harris J. Sklar
967 F.2d 852 (Third Circuit, 1992)
E.T. Browne Drug Co. v. Cococare Products, Inc.
538 F.3d 185 (Third Circuit, 2008)
Staci Sconiers v. United States
896 F.3d 595 (Third Circuit, 2018)
Murphy v. Provident Mutual Life Insurance
923 F.2d 923 (Second Circuit, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
Engage Healthcare Comm LLC v. Intellisphere LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/engage-healthcare-comm-llc-v-intellisphere-llc-ca3-2019.